Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Favrille Beneficiary Owners $12.2M buy of PTSC stock...

RE: Favrille Beneficiary Owners $12.2M buy of PTSC stock...

posted on Mar 10, 2006 06:36AM
Not sure from the link whether they bought PSTC stock or somebody else since the headline includes info on more than one company. Have you looked further?
Share
New Message
Please login to post a reply